Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Endocrine, 53, 3, S. 791-800
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2016
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Springer
- (wann)
-
2016
- Urheber
-
Wolf, Herta
Kroiss, Matthias
Nakajo, Masatoyo
Mügge, Dirk O.
Hahner, Stefanie
Faßnacht, Martin
Schirbel, Andreas
Bluemel, Christina
Higuchi, Takahiro
Papp, Laszló
Zsótér, Norbert
Buck, Andreas K.
Bundschuh, Ralph A.
Lapa, Constantin Frederik Victor
- DOI
-
10.1007/s12020-016-0970-1
- URN
-
urn:nbn:de:bvb:384-opus4-633771
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wolf, Herta
- Kroiss, Matthias
- Nakajo, Masatoyo
- Mügge, Dirk O.
- Hahner, Stefanie
- Faßnacht, Martin
- Schirbel, Andreas
- Bluemel, Christina
- Higuchi, Takahiro
- Papp, Laszló
- Zsótér, Norbert
- Buck, Andreas K.
- Bundschuh, Ralph A.
- Lapa, Constantin Frederik Victor
- Universität Augsburg
- Springer
Entstanden
- 2016
Ähnliche Objekte (12)
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
The role of molecular profiling in adrenocortical carcinoma
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
The role of molecular profiling in adrenocortical carcinoma
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie